Pharmacokinetic–pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia

Author： Hsyu Poe-Hirr Mould Diane Upton Richard Amantea Michael

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.71, Iss.1, 2013-01, pp. : 209-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 791-796

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients

By Paul T.

Indian Journal of Hematology and Blood Transfusion, Vol. 26, Iss. 2, 2010-06 ,pp. : 56-61

Springer Publishing Company

Access to resources Recommend Favorite

Methylation analysis of the DAPK1 gene in imatinibresistant chronic myeloid leukemia patients

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 399-404

Spandidos Publications

Access to resources Recommend Favorite

Normal platelet counts mask abnormal thrombopoiesis in patients with chronic myeloid leukemia

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2390-2394

Spandidos Publications

Access to resources Recommend Favorite